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ABSTRACT: The search for novel ultrasound contrast agents has now led to the use of 
nanoparticles due to their ability to generate contrast, amalgamation of numerous 
properties, adequate circulation times and satisfactory safety issues. Experiences with these 
nano particles promise not only in-depth knowledge of disease processes but also the early 
effects of therapy. In this review we discuss how nanoparticles have evolved for use as 
ultrasound contrast agents. 
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INTRODUCTION
ᴪ 
 
Ultrasound imaging involves the use of high 
frequency ultrasound beams to non-invasively 
visualize the inner structures of human body. Thus, 
gross findings of a pathology that is merely 
suspected on clinical examination or confirmed 
after appropriate laboratory investigations can 
further be validated by directly visualizing it in 
vivo with the help of ultrasound. Often it is difficult 
to differentiate between what is normal from what 
is abnormal particularly in the early stages as the 
differences on ultrasound imaging might be very 
subtle. This is particularly important when a 
malignant lesion is involved in differential 
diagnosis. To a novice in this field both the 
conditions might appear similar at early stages. It is 
then, that there arises a need for some agent that 
can enhance visualization. 
 
HISTORY 
 
To solve this dilemma, contrast agents were 
introduced in sonographic imaging. The history 
dates back to 1960`s when the heart and the aortic 
root
1 could be better visualized  sonographically by 
injecting agitated liquid containing air bubbles 
simultaneously while performing the scans. Since 
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then, efforts are being made to develop optimum 
ultrasound contrast agents. 
 
MECHANISMS INVOLVED 
 
The enhanced difference in acoustic impedance on 
grey scale imaging, between the contrast agent and 
surrounding tissue helps in better visualization and 
characterization of lesion
2. Microvasculature as 
well as parenchymal vascularity is also better 
detected on colour and power Doppler following 
contrast usage
3. 
 
EXAMPLES AND INDICATIONS OF 
CURRENTLY AVAILABLE CONTRAST 
AGENTS 
 
•  Albunex consisted of air filled human albumin 
microspheres of size 1-8 µ for use in 
myocardial contrast echocardiography
4. 
 Now 
Albunex is no longer in circulation. 
•  Echogen is a dodecafluopentane droplet 
emulsion to better visualize enhancement in 
Heart, Liver and Renal system.
5 
•  Perflubron emulsion for lymphography.
6 
•  Simethicone-coated cellulose based suspension 
used as an oral gastrointestinal contrast agent.
7 
 
LIMITATIONS OF CURRENTLY 
AVAILABLE CONTRAST AGENTS 
 
The main limiting step has been the very short 
useful life span of the bubbles in the contrast once 
they are introduced in the vascular system, because Kulkarni et al / The New Face of Ultrasound Imaging 
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the contrast agents act by enhancing the backscatter 
of reflected ultrasound echoes in the tissues that 
bear them. Other factors which limit the usage of 
the currently available contrast agents are artifacts 
like colour blooming, spectral bubble noise and 
increase in maximum Doppler shift
8. Adverse 
effects like flushing of upper half of body and face, 
shortness of breath, chest heaviness, dizziness etc 
are also been reported. 
 
NANOTECHNOLOGY ENABLED NEW 
ROAD OF NANOBUBBLES 
 
Nanoparticles
9 are made from natural proteins and 
polymers, artificial polymers, dendrimers, 
fullerenes and other carbon-based structures, lipid-
water micelles, viral capsids, metals, metal oxides, 
and ceramics. Signal generators incorporated into 
nanoparticles include iron oxide, gadolinium, 
fluorine, iodine, bismuth, radionuclides, quantum 
dots and metal nanoclusters. 
Tumour blood vessels have open pores that permit 
entry and retain nanoparticles in the tumour 
vasculature, so that they can be effectively used as 
ultrasound contrast agents. Nanoparticles can have 
multiple bioadhesive sites and share functionalities 
with many subcellular organelles like ribosomes, 
proteasomes, ion channels and transport vesicles. 
Use of imaging for sentinel node localisation and 
stem cell tracking is therefore also possible
9. Both 
the contrast medium as well as therapeutic drug can 
be delivered, by the same nanoparticles. 
Nano-sized ultrasound contrast agents are being 
investigated by using Poly (D, L-lactic acid)
10 as a 
platform material. Sublimable porogens such as 
camphor make the nanoparticles hollow , which are 
then filled   with hydrophobic and dense bioinert 
gas Sulfur hexafluoride gas (SF6), is then 
introduced which increases echogenicity by 
enhance backscattered signals. These nanoparticles 
have approximately 200 nm size with a unimodal 
distribution and spherical shape and can be 
accumulated at solid tumor sites passively via well 
known EPR (Enhanced Permeability and 
Retention) effect. 
Polyoxyethylene 40 stearate
11 is being increasingly 
used as an alternative surfactant for generating 
nanobubbles because it is biocompatible, 
degradable and non-toxic. 
Poly (Lactic-co-glycolic) acid
12  can be used as a 
carrier for imaging contrast agents. The nanocage 
of elemental silver surrounding a therapeutic core 
consisting of the biodegrade polymer poly (Lactic-
co-glycolic) acid with encapsulated 
chemotherapeutic drugs provides the contrast 
property for better imaging. 
 
 
 
ADVANTAGES OF NANOPARTICLES AS 
ULTRASOUND CONTRAST AGENTS 
 
•  Echogenicity of blood and surrounding tissues 
is almost similar as human body is composed 
mostly of water. This makes it difficult on non 
contrast ultrasound to clearly visualize the 
interface between the tissue and blood, degree 
of blood flow, and perfusion or the using 
traditional ultrasound. These contrast agents 
improve visualization.
13 
•  They allow real-time blood flow assessment.
14 
•  Radiation free nature makes it safer than other 
imaging.
14 
•  Sonography is very cost-efficient and widely 
available as against other imaging modalities, 
such as MRI, PET and SPECT.
15 
•  Less amount of intravenous dosage of 
sonography contrast is needed, than for other 
imaging modalities such as  MRI contrast 
agents.
15 
 
DISADVANTAGES 
 
•  The ultrasonic frequency needs more careful 
monitoring as ultrasound produces more heat 
with increase in frequency. 
•  Microvasculature rupture can result  from 
simultaneous large number of nanobubble 
destruction.
16 
•  Targeting ligands can be immunogenic, since 
current targeting ligands used in preclinical 
experiments are derived from animal culture.
16 
•  Low targeted microbubble adhesion efficiency, 
which means that only a small fraction of 
injected microbubbles bind to the area of 
interest.
17 
 
CONCLUSION 
 
Nanoparticles are thus unleashing newer power of 
imaging towards uncharted frontiers. This will 
surely lead to early diagnosis and prompt treatment. 
Nanotechnology thus holds a new promise for 
better health and longevity. 
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